Decreased expression of human cathelicidin LL-37 and human β-defensin-2 (hBD-2) in lesions of atopic dermatitis compared to amplified expression in psoriatic lesions may help account for the increased susceptibility to secondary bacterial infection that is seen in patients with atopic dermatitis but not psoriasis [16]. Here, CAMP is linked to atopic eczema.